| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |